Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

RPTPε promotes M2-polarized macrophage migration through ROCK2 signaling and podosome formation.

Lapointe F, Turcotte S, Roy J, Bissonnette E, Rola-Pleszczynski M, Stankova J.

J Cell Sci. 2020 Jan 21;133(5). pii: jcs234641. doi: 10.1242/jcs.234641.

PMID:
31722979
2.

Human leukocytes differentially express endocannabinoid-glycerol lipases and hydrolyze 2-arachidonoyl-glycerol and its metabolites from the 15-lipoxygenase and cyclooxygenase pathways.

Turcotte C, Dumais É, Archambault AS, Martin C, Blanchet MR, Bissonnette É, Boulet LP, Laviolette M, Di Marzo V, Flamand N.

J Leukoc Biol. 2019 Dec;106(6):1337-1347. doi: 10.1002/JLB.3A0919-049RRR. Epub 2019 Sep 26.

PMID:
31556464
3.

CD200 in asthma.

Lauzon-Joset JF, Marsolais D, Tardif-Pellerin É, Patoine D, Bissonnette EY.

Int J Biochem Cell Biol. 2019 Jul;112:141-144. doi: 10.1016/j.biocel.2019.05.003. Epub 2019 May 8.

PMID:
31077782
4.

Comparison of eight 15-lipoxygenase (LO) inhibitors on the biosynthesis of 15-LO metabolites by human neutrophils and eosinophils.

Archambault AS, Turcotte C, Martin C, Provost V, Larose MC, Laprise C, Chakir J, Bissonnette É, Laviolette M, Bossé Y, Flamand N.

PLoS One. 2018 Aug 17;13(8):e0202424. doi: 10.1371/journal.pone.0202424. eCollection 2018.

5.

A unique event for the francophone respiratory community.

Boulet LP, Bissonnette E, Humbert M, Maître B, Pigearias B.

Eur Respir J. 2017 Oct 5;50(4). pii: 1701479. doi: 10.1183/13993003.01479-2017. Print 2017 Oct. No abstract available.

6.

A sphingosine-1-phosphate receptor 1 agonist inhibits tertiary lymphoid tissue reactivation and hypersensitivity in the lung.

Huppé CA, Blais Lecours P, Lechasseur A, Gendron DR, Lemay AM, Bissonnette EY, Blanchet MR, Duchaine C, Morissette MC, Rosen H, Marsolais D.

Mucosal Immunol. 2018 Jan;11(1):112-119. doi: 10.1038/mi.2017.37. Epub 2017 Apr 19.

PMID:
28422187
7.

A Phosphorylatable Sphingosine Analog Induces Airway Smooth Muscle Cytostasis and Reverses Airway Hyperresponsiveness in Experimental Asthma.

Gendron DR, Lecours PB, Lemay AM, Beaulieu MJ, Huppé CA, Lee-Gosselin A, Flamand N, Don AS, Bissonnette É, Blanchet MR, Laplante M, Bourgoin SG, Bossé Y, Marsolais D.

Front Pharmacol. 2017 Feb 21;8:78. doi: 10.3389/fphar.2017.00078. eCollection 2017.

8.

Treatment with a sphingosine analog after the inception of house dust mite-induced airway inflammation alleviates key features of experimental asthma.

Gendron D, Lemay AM, Tremblay C, Lai LJ, Langlois A, Bernatchez É, Flamand N, Blanchet MR, Don AS, Bossé Y, Bissonnette É, Marsolais D.

Respir Res. 2015 Feb 3;16:7. doi: 10.1186/s12931-015-0180-z.

9.

Lung CD200 Receptor Activation Abrogates Airway Hyperresponsiveness in Experimental Asthma.

Lauzon-Joset JF, Langlois A, Lai LJ, Santerre K, Lee-Gosselin A, Bossé Y, Marsolais D, Bissonnette EY.

Am J Respir Cell Mol Biol. 2015 Aug;53(2):276-84. doi: 10.1165/rcmb.2014-0229OC.

PMID:
25569356
10.

Fibroblast growth factor-2 is a sputum remodeling biomarker of severe asthma.

Bissonnette ÉY, Madore AM, Chakir J, Laviolette M, Boulet LP, Hamid Q, Bergeron C, Maghni K, Laprise C.

J Asthma. 2014 Mar;51(2):119-26. doi: 10.3109/02770903.2013.860164. Epub 2013 Nov 25.

PMID:
24188024
11.

Dysregulation of alveolar macrophages unleashes dendritic cell-mediated mechanisms of allergic airway inflammation.

Lauzon-Joset JF, Marsolais D, Langlois A, Bissonnette EY.

Mucosal Immunol. 2014 Jan;7(1):155-64. doi: 10.1038/mi.2013.34. Epub 2013 May 29.

PMID:
23715174
12.

Regulation of normal and cystic fibrosis airway epithelial repair processes by TNF-α after injury.

Maillé E, Trinh NT, Privé A, Bilodeau C, Bissonnette E, Grandvaux N, Brochiero E.

Am J Physiol Lung Cell Mol Physiol. 2011 Dec;301(6):L945-55. doi: 10.1152/ajplung.00149.2011. Epub 2011 Sep 9.

13.

Alveolar macrophages reduce airway hyperresponsiveness and modulate cytokine levels.

Careau E, Turmel V, Lauzon-Joset JF, Bissonnette EY.

Exp Lung Res. 2010 Jun;36(5):255-61. doi: 10.3109/01902140903410757.

PMID:
20497019
14.

Alveolar macrophages in allergic asthma: an expression signature characterized by heat shock protein pathways.

Madore AM, Perron S, Turmel V, Laviolette M, Bissonnette EY, Laprise C.

Hum Immunol. 2010 Feb;71(2):144-50. doi: 10.1016/j.humimm.2009.11.005. Epub 2009 Nov 12.

PMID:
19913588
15.

Comparison of two in vitro models of cigarette smoke exposure.

St-Laurent J, Proulx LI, Boulet LP, Bissonnette E.

Inhal Toxicol. 2009 Nov;21(13):1148-53. doi: 10.3109/08958370902926692.

PMID:
19852558
16.

Cigarette smoke differently alters normal and ovalbumin-sensitized bronchial epithelial cells from rat.

St-Laurent J, Boulet LP, Bissonnette E.

J Asthma. 2009 Aug;46(6):577-81. doi: 10.1080/02770900902912646.

PMID:
19657897
17.

Alveolar macrophage subpopulations in bronchoalveolar lavage and induced sputum of asthmatic and control subjects.

St-Laurent J, Turmel V, Boulet LP, Bissonnette E.

J Asthma. 2009 Feb;46(1):1-8. doi: 10.1080/02770900802444211.

PMID:
19191129
18.

Coumarinic derivatives show anti-inflammatory effects on alveolar macrophages, but their anti-elastase activity is essential to reduce lung inflammation in vivo.

Bissonnette EY, Tremblay GM, Turmel V, Pirotte B, Reboud-Ravaux M.

Int Immunopharmacol. 2009 Jan;9(1):49-54. doi: 10.1016/j.intimp.2008.09.009. Epub 2008 Oct 7.

PMID:
18840548
19.

Alveolar macrophages from allergic lungs are not committed to a pro-allergic response and can reduce airway hyperresponsiveness following ex vivo culture.

Pouliot P, Spahr A, Careau E, Turmel V, Bissonnette EY.

Clin Exp Allergy. 2008 Mar;38(3):529-38. doi: 10.1111/j.1365-2222.2007.02924.x. Epub 2008 Jan 14.

20.

Effects of protease inhibitors on mediator preservation in the supernatant of induced sputum.

St-Laurent J, Prince P, Boulay ME, Bissonnette E, Boulet LP.

J Immunoassay Immunochem. 2007;28(4):385-94.

PMID:
17885891
21.

Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2.

Ménard G, Turmel V, Bissonnette EY.

Clin Exp Immunol. 2007 Nov;150(2):340-8. Epub 2007 Sep 5.

22.

Alveolar macrophage cytotoxic activity is inhibited by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a carcinogenic component of cigarette smoke.

Proulx LI, Paré G, Bissonnette EY.

Cancer Immunol Immunother. 2007 Jun;56(6):831-8. Epub 2006 Nov 10.

PMID:
17096151
23.

Mast cells regulate procollagen I (alpha 1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4 delta 2 ratio.

Plante S, Semlali A, Joubert P, Bissonnette E, Laviolette M, Hamid Q, Chakir J.

J Allergy Clin Immunol. 2006 Jun;117(6):1321-7. Epub 2006 Feb 21.

PMID:
16750993
24.

Antigen sensitization modulates alveolar macrophage functions in an asthma model.

Careau E, Proulx LI, Pouliot P, Spahr A, Turmel V, Bissonnette EY.

Am J Physiol Lung Cell Mol Physiol. 2006 May;290(5):L871-9.

25.

Comparison of cell fixation methods of induced sputum specimens: an immunocytochemical analysis.

St-Laurent J, Boulay ME, Prince P, Bissonnette E, Boulet LP.

J Immunol Methods. 2006 Jan 20;308(1-2):36-42. Epub 2005 Nov 21.

PMID:
16325848
26.

Interleukin-4 production by human alveolar macrophages.

Pouliot P, Turmel V, Gélinas E, Laviolette M, Bissonnette EY.

Clin Exp Allergy. 2005 Jun;35(6):804-10.

PMID:
15969673
27.

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a component of tobacco smoke, modulates mediator release from human bronchial and alveolar epithelial cells.

Proulx LI, Gaudreault M, Turmel V, Augusto LA, Castonguay A, Bissonnette EY.

Clin Exp Immunol. 2005 Apr;140(1):46-53.

28.

PCT-233, a novel modulator of pro- and anti-inflammatory cytokine production.

Bissonnette EY, Proulx LI, Turmel V, Drouin R, Purcell M.

Clin Exp Immunol. 2004 Mar;135(3):440-7.

29.

Adoptive transfer of alveolar macrophages abrogates bronchial hyperresponsiveness.

Careau E, Bissonnette EY.

Am J Respir Cell Mol Biol. 2004 Jul;31(1):22-7. Epub 2004 Feb 12.

PMID:
14962974
30.
31.

Immunomodulatory effects of the tobacco-specific carcinogen, NNK, on alveolar macrophages.

Therriault MJ, Proulx LI, Castonguay A, Bissonnette EY.

Clin Exp Immunol. 2003 May;132(2):232-8.

32.

Episodic ataxia type 1 mutations in the human Kv1.1 potassium channel alter hKvbeta 1-induced N-type inactivation.

Maylie B, Bissonnette E, Virk M, Adelman JP, Maylie JG.

J Neurosci. 2002 Jun 15;22(12):4786-93.

33.

Endothelins regulate mediator production of rat tissue-cultured mucosal mast cells. Up-regulation of Th1 and inhibition of Th2 cytokines.

Coulombe M, Battistini B, Stankova J, Pouliot P, Bissonnette EY.

J Leukoc Biol. 2002 May;71(5):829-36.

PMID:
11994508
34.
35.
36.

Priming of alveolar macrophages by leukotriene D(4): potentiation of inflammation.

Ménard G, Bissonnette EY.

Am J Respir Cell Mol Biol. 2000 Oct;23(4):572-7.

PMID:
11017925
37.

Redundancy or cell-type-specific regulation? Tumour necrosis factor in alveolar macrophages and mast cells.

Déry RE, Lin TJ, Befus AD, Milne CD, Moqbel R, Ménard G, Bissonnette EY.

Immunology. 2000 Mar;99(3):427-34.

38.

Importance of histamine in the cytokine network in the lung through H2 and H3 receptors: stimulation of IL-10 production.

Sirois J, Ménard G, Moses AS, Bissonnette EY.

J Immunol. 2000 Mar 15;164(6):2964-70.

39.

IFN-gamma potentiates the release of TNF-alpha and MIP-1alpha by alveolar macrophages during allergic reactions.

Déry RE, Bissonnette EY.

Am J Respir Cell Mol Biol. 1999 Mar;20(3):407-12.

PMID:
10030838
40.
42.

Mast cells in asthma.

Bissonnette EY, Befus AD.

Can Respir J. 1998 Jan-Feb;5(1):23-4. Review. No abstract available.

PMID:
9556504
43.

Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells.

Bissonnette EY, Befus AD.

J Allergy Clin Immunol. 1997 Dec;100(6 Pt 1):825-31.

PMID:
9438493
44.

TGF-beta1 inhibits the release of histamine and tumor necrosis factor-alpha from mast cells through an autocrine pathway.

Bissonnette EY, Enciso JA, Befus AD.

Am J Respir Cell Mol Biol. 1997 Mar;16(3):275-82.

PMID:
9070612
46.

Histamine inhibits tumor necrosis factor alpha release by mast cells through H2 and H3 receptors.

Bissonnette EY.

Am J Respir Cell Mol Biol. 1996 Jun;14(6):620-6.

PMID:
8652190
47.
48.

Cytokine and drug modulation of TNF alpha in mast cells.

Lin TJ, Enciso A, Bissonnette EY, Szczepek A, Befus AD.

Adv Exp Med Biol. 1996;409:279-85. Review. No abstract available.

PMID:
9095255
49.

Supplemental Content

Loading ...
Support Center